The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1514
Subscribers: Log in to read full issue.  Not a subscriber?  Subscribe or purchase issue.
Drugs for Migraine
Revised 2/1/18: In Table 2, Sumavel DosePro has been discontinued.
 TREATMENT OF MIGRAINE 

An oral nonopioid analgesic may be sufficient for treatment of mild to moderate migraine without severe nausea or vomiting. A triptan is the drug of choice for treatment of moderate to severe migraine.1,2 Use of a triptan early in an attack when pain is still mild to moderate in intensity improves headache response and reduces recurrence rates.

ANALGESICS – Aspirin and acetaminophen, used alone or together in combination with caffeine (Excedrin Migraine, and others), and nonsteroidal anti-inflammatory drugs (NSAIDs) such as naproxen sodium (Aleve, and others) and ibuprofen (Advil, Motrin, and generics) are effective in relieving mild to moderate migraine pain.3-5 The NSAID diclofenac is FDA-approved as a powder for oral ... more      

The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this issue?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this issue:
Title: Issue 1514
 Downloadable, electronic issue - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.
Recommend to your librarian